Mulroy Michael H.
- SEC CIK
- 0001509725
No open-market purchases or sales filed in the past year.
Current role at each company
- LCTX Lineage Cell Therapeutics, Inc.Directoras of Jul 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mulroy Michael H. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 (view filing) | Nov 22 | 3 days | Mulroy Michael H.Director | PPurchase | +40.0K | $0.57 | +$22.8K | +15.5%298.6K after | |
| Mar 25, 2022 (view filing) | Mar 24 | 1 day | Mulroy Michael H.Director | PPurchaseCommon Shares, no par value | +7.00K | $1.40 | +$9.80K | +2.8%258.6K after |